Cargando…
Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Allergology. Production and hosting by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648507/ https://www.ncbi.nlm.nih.gov/pubmed/33208274 http://dx.doi.org/10.1016/j.alit.2020.10.005 |
_version_ | 1783607125946138624 |
---|---|
author | Tanabe, Naoya Matsumoto, Hisako Hamada, Satoshi Ito, Isao Hirai, Toyohiro |
author_facet | Tanabe, Naoya Matsumoto, Hisako Hamada, Satoshi Ito, Isao Hirai, Toyohiro |
author_sort | Tanabe, Naoya |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7648507 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Japanese Society of Allergology. Production and hosting by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76485072020-11-09 Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia Tanabe, Naoya Matsumoto, Hisako Hamada, Satoshi Ito, Isao Hirai, Toyohiro Allergol Int Letter to the Editor Japanese Society of Allergology. Production and hosting by Elsevier B.V. 2021-04 2020-11-07 /pmc/articles/PMC7648507/ /pubmed/33208274 http://dx.doi.org/10.1016/j.alit.2020.10.005 Text en © 2020 Japanese Society of Allergology. Production and hosting by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Tanabe, Naoya Matsumoto, Hisako Hamada, Satoshi Ito, Isao Hirai, Toyohiro Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia |
title | Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia |
title_full | Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia |
title_fullStr | Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia |
title_full_unstemmed | Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia |
title_short | Dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia |
title_sort | dupilumab maintenance therapy in an asthmatic patient with coronavirus disease 2019 pneumonia |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648507/ https://www.ncbi.nlm.nih.gov/pubmed/33208274 http://dx.doi.org/10.1016/j.alit.2020.10.005 |
work_keys_str_mv | AT tanabenaoya dupilumabmaintenancetherapyinanasthmaticpatientwithcoronavirusdisease2019pneumonia AT matsumotohisako dupilumabmaintenancetherapyinanasthmaticpatientwithcoronavirusdisease2019pneumonia AT hamadasatoshi dupilumabmaintenancetherapyinanasthmaticpatientwithcoronavirusdisease2019pneumonia AT itoisao dupilumabmaintenancetherapyinanasthmaticpatientwithcoronavirusdisease2019pneumonia AT hiraitoyohiro dupilumabmaintenancetherapyinanasthmaticpatientwithcoronavirusdisease2019pneumonia |